TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $103,000 | +5050.0% | 17,406 | +3667.5% | 0.00% | – |
| Q2 2022 | $2,000 | -98.0% | 462 | -91.1% | 0.00% | -100.0% |
| Q4 2021 | $99,000 | +76.8% | 5,186 | +256.2% | 0.00% | +50.0% |
| Q2 2021 | $56,000 | +1766.7% | 1,456 | +464.3% | 0.00% | +100.0% |
| Q1 2020 | $3,000 | -85.0% | 258 | -85.9% | 0.00% | -80.0% |
| Q4 2019 | $20,000 | 0.0% | 1,829 | -49.7% | 0.01% | -28.6% |
| Q3 2018 | $20,000 | -4.8% | 3,637 | -18.9% | 0.01% | -66.7% |
| Q4 2016 | $21,000 | – | 4,485 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |